Aquestive Therapeutics, Inc. AQST
3.54 USD -0.07 (-1.94%)
At closeNov 9, 2026, 4:00 PM EST
3.50 -0.04 -1.13%
After hours · Nov 9, 4:00 PM ET
3.37 Day range 3.67
2.93 52-week range 6.74
- YTD
- -45.20%
- 1 year
- -41.39%
Revenue & Expenses
Revenue by
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 44.55M | 57.56M | 50.58M | 47.68M | 50.83M | |
| 25.99M | 39.69M | 29.75M | 28.29M | 35.84M | |
| -71.05M | -30.77M | -15.10M | -42.07M | -34.68M | |
| -83.78M | -44.14M | -7.87M | -54.41M | -70.54M | |
| -0.78 | -0.51 | -0.13 | -1.12 | -1.85 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 121.17M | 71.55M | 23.87M | 27.27M | 28.02M | |
| 160.43M | 101.42M | 57.42M | 57.07M | 61.99M | |
| 194.09M | 161.58M | 163.91M | 175.62M | 144.13M | |
| 131.44M | 121.85M | 112.57M | 122.75M | 116.70M | |
| -33.66M | -60.16M | -106.49M | -118.55M | -82.13M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -52.43M | -35.76M | -6.38M | -9.82M | -32.98M | |
| -562.00K | -159.00K | -995.00K | -2.52M | -913.00K | |
| 102.62M | 83.59M | 3.97M | 11.59M | 30.11M | |
| -562.00K | -159.00K | -995.00K | -1.02M | -913.00K | |
| 49.62M | 47.67M | -3.40M | -751.00K | -3.78M |